Results demonstrated that when patients with plaque psoriasis applied topical roflumilast once per day they reported clear skin as well as i

“In some diseases, cells lose their ability to differentiate, and reproduce more rapidly. Being able to redirect cells back to their usual l

Guselkumab, a biologic therapy that is part of a new class of agents targeting interleukin (IL)-23 without blocking IL-12, was approved...

“After a series of tests carried out by Dr. Satveer Mahil at St. John’s Institute of Dermatology [at King’s College, London], we determined

Canadian investigators have determined that apremilast—an oral phosphodiesterase 4 inhibitor—can be safely and effectively combined with...